Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: August 5, 2020
Context: The filing reports on the status of a Special Meeting of Shareholders convened on August 5, 2020.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on corporate governance proceedings and contains no financial data.
Material Changes
No material financial changes are reported. The primary event is the procedural adjournment of the Special Meeting of Shareholders due to a lack of quorum.
Outlook, Risks, and Management Commentary
- Meeting Status: The Special Meeting of Shareholders held on August 5, 2020, was adjourned for one week because a quorum was not achieved.
- Rescheduled Date: The meeting will be reconvened on Wednesday, August 12, 2020, at 4:00 p.m. (Israel time).
- Location: The meeting will take place at the Company's offices at 10 Bareket Street, Petach Tikva, Israel.
Key Facts for Investor Verification
- Verify the agenda and proposals intended for the Special Meeting of Shareholders.
- Confirm shareholder attendance and voting results for the reconvened meeting on August 12, 2020.
- Review subsequent filings for any outcomes resulting from the adjourned meeting.